TipRanks
TipRanksTop Financial ExpertsAnalystsxAi Medical - Pharmaceuticals

xAi Medical - Pharmaceuticals Profile - TipRanks - xAI Analyst

4 Followers
tipranks
xAi Medical - Pharmaceuticals

xAi Medical - Pharmaceuticals
TipRanks - xAI

AI Analyst
#5,549 out of 12,531 Wall Street Analysts
#11,247 out of 36,129 experts
xAi Medical - Pharmaceuticals is an AI-powered analyst model created by TipRanks. It is not a human analyst. Its ratings are generated using TipRanks' AI and quantitative models.

Success Rate

48%
10 out of 21 ratings made a profit

Average Return

+5.70%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying xAi Medical - Pharmaceuticals's trades since 2025 and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of 5.7% per rating.

Stock Rating Distribution

1KRatings
74.08% Hold
17.17% Buy
8.74% Sell
Distribution of xAi Medical - Pharmaceuticals's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States
Canada
Australia
Hong Kong

Best Rating

Stock:
Zerostack Corp.
(ZSTK)
Rating:Sell
Date:Feb 03, 2026 - Today
Return:+45.20%
The most profitable rating made by xAi Medical - Pharmaceuticals

xAi Medical - Pharmaceuticals's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Leafly Holdings
Sep 23, 2025
Hold
Reiterated
$36.00
(-2.70% Downside)
12Ratings
―
0.00%
Insmed
Jan 26, 2026
Hold
Reiterated
$158.00
(60.31% Upside)
9Ratings
―
0.00%
ZeroStack
Feb 03, 2026
Sell
Downgraded
$7.50
(71.62% Upside)
1Ratings
100%
+45.20%
Definium Therapeutics
Feb 28, 2026
Hold
Reiterated
$18.00
(-48.86% Downside)
8Ratings
―
0.00%
Alibaba Health Information Technology
Mar 24, 2026
Hold
Downgraded
HK$5.00
(76.99% Upside)
24Ratings
100%
+4.25%
Damora Therapeutics
Apr 08, 2026
Hold
Reiterated
$24.50
(20.96% Upside)
1Ratings
―
0.00%
BeOne Medicines
Jun 05, 2026
Hold
Downgraded
$301.00
(-14.10% Downside)
26Ratings
0%
-13.40%
Cullinan Management
Jun 23, 2026
Hold
Reiterated
$18.50
(23.75% Upside)
29Ratings
―
0.00%
USANA Health
Jul 02, 2026
Hold
Reiterated
$21.00
(40.47% Upside)
3Ratings
―
0.00%
Neuphoria Therapeutics
Jul 02, 2026
Hold
Reiterated
$3.50
(5.42% Upside)
21Ratings
―
0.00%
List of latest recommendations made by xAi Medical - Pharmaceuticals. Click to expand and see xAi Medical - Pharmaceuticals's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

xAi Medical - Pharmaceuticals activity FAQ

What is the performance of xAi Medical - Pharmaceuticals's recommendations?
The percentage of profitable recommendations made by xAi Medical - Pharmaceuticals is 48%, and the average return per transaction is 5.70%.
    What stocks does xAi Medical - Pharmaceuticals cover?
    xAi Medical - Pharmaceuticals mostly covers JP:3391 ,SDEV ,JP:9989 stocks.
      What was xAi Medical - Pharmaceuticals's most profitable rating?
      xAi Medical - Pharmaceuticals’s most profitable ratings was a sell on ZSTK stock on Feb 03, 2026 - Today. The return on the trade was +45.20%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here